Atropos Health, a leader in generating high-quality real-world evidence (RWE) from clinical data, has unveiled a game-changing integration: its Atropos Evidence™ Agent now works seamlessly within Microsoft Teams. This allows multidisciplinary care teams to access personalized, patient-specific RWE on demand during collaborative discussions transforming how healthcare professionals handle complex cases.

The integration enables users to “call” the Evidence Agent directly in a Teams meeting. The AI agent analyzes de-identified real-world clinical data, patient context, and discussion points to generate tailored evidence-based insights instantly. This is particularly valuable in scenarios like tumor boards, where oncologists and specialists debate treatment options, or care coordination sessions managing multifaceted patient needs.

By keeping everything within the familiar Microsoft Teams environment, the tool eliminates the need to switch between systems, reducing workflow friction and supporting timely decisions. This shifts care dynamics from reactive searches to proactive, evidence-driven collaboration, helping resolve previously unanswerable questions that often delay patient management.

The launch builds on Atropos Health’s ongoing partnership with Microsoft. It follows an earlier announcement of integration with Microsoft Dragon Copilot an AI clinical assistant that ambiently captures patient visits and delivers personalized evidence into electronic health records (EHRs) using data from sources like Stanford Health Care.

Atropos Health’s broader ecosystem includes the Evidence Network, accessing vast de-identified datasets, and tools like Alexandria®, a library of over 100,000 novel studies. The Evidence Agent leverages proprietary AI models rigorously tested to minimize errors and hallucinations, ensuring high-quality, publication-grade outputs.

This advancement comes amid growing adoption of agentic AI in healthcare, where specialized agents collaborate within platforms like Microsoft 365. For life sciences and providers, it accelerates evidence generation from months to minutes, enhancing personalized medicine at the point of care.

Industry observers see this as a milestone in embedding RWE into daily clinical practice, potentially improving outcomes in oncology, rare diseases, and value-based care. With deployments already underway at institutions like Stanford Health Care, the integration underscores Atropos Health’s push to make real-world data actionable for every patient encounter.

As healthcare embraces AI orchestration, tools like this could redefine team-based decision-making, fostering efficiency and precision in an increasingly data-rich environment.